Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 20.15 Billion USD | -6.53% |
| 2022 | 21.56 Billion USD | -8.09% |
| 2021 | 23.45 Billion USD | -11.13% |
| 2020 | 26.39 Billion USD | -3.45% |
| 2019 | 27.34 Billion USD | -5.44% |
| 2018 | 28.91 Billion USD | -10.96% |
| 2017 | 32.47 Billion USD | -9.29% |
| 2016 | 35.8 Billion USD | 259.15% |
| 2015 | 9.96 Billion USD | -3.48% |
| 2014 | 10.32 Billion USD | -15.29% |
| 2013 | 12.19 Billion USD | -17.17% |
| 2012 | 14.71 Billion USD | 1.39% |
| 2011 | 14.51 Billion USD | 162.54% |
| 2010 | 5.52 Billion USD | -12.78% |
| 2009 | 6.33 Billion USD | -24.92% |
| 2008 | 8.44 Billion USD | 62.74% |
| 2007 | 5.18 Billion USD | -2.61% |
| 2006 | 5.32 Billion USD | 147.91% |
| 2005 | 2.14 Billion USD | 3.62% |
| 2004 | 2.07 Billion USD | 42.08% |
| 2003 | 1.45 Billion USD | -23.17% |
| 2002 | 1.89 Billion USD | 30.72% |
| 2001 | 1.45 Billion USD | 25.79% |
| 2000 | 1.15 Billion USD | 73.05% |
| 1999 | 667.67 Million USD | 26.89% |
| 1998 | 526.2 Million USD | 42.33% |
| 1997 | 369.7 Million USD | -26.4% |
| 1996 | 502.3 Million USD | 72.49% |
| 1995 | 291.2 Million USD | 32.91% |
| 1994 | 219.1 Million USD | 22.68% |
| 1993 | 178.6 Million USD | 33.58% |
| 1992 | 133.7 Million USD | 16.26% |
| 1991 | 115 Million USD | -7.26% |
| 1990 | 124 Million USD | 35.67% |
| 1989 | 91.4 Million USD | 23.01% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 19.93 Billion USD | -1.07% |
| 2024 Q2 | 18.92 Billion USD | -5.1% |
| 2023 Q1 | 21.03 Billion USD | -2.43% |
| 2023 Q3 | 20.29 Billion USD | -3.42% |
| 2023 Q2 | 21.01 Billion USD | -0.1% |
| 2023 Q4 | 20.15 Billion USD | -0.71% |
| 2023 FY | 20.15 Billion USD | -6.53% |
| 2022 Q4 | 21.56 Billion USD | -0.27% |
| 2022 Q1 | 23.31 Billion USD | -0.64% |
| 2022 Q2 | 22.45 Billion USD | -3.68% |
| 2022 FY | 21.56 Billion USD | -8.09% |
| 2022 Q3 | 21.62 Billion USD | -3.71% |
| 2021 Q2 | 25.57 Billion USD | 0.59% |
| 2021 Q1 | 25.42 Billion USD | -3.68% |
| 2021 Q4 | 23.45 Billion USD | -2.95% |
| 2021 Q3 | 24.17 Billion USD | -5.49% |
| 2021 FY | 23.45 Billion USD | -11.13% |
| 2020 Q2 | 26.67 Billion USD | 0.62% |
| 2020 Q3 | 26.09 Billion USD | -2.2% |
| 2020 Q1 | 26.51 Billion USD | -3.03% |
| 2020 Q4 | 26.39 Billion USD | 1.17% |
| 2020 FY | 26.39 Billion USD | -3.45% |
| 2019 Q4 | 27.34 Billion USD | 0.02% |
| 2019 Q2 | 29.15 Billion USD | 0.36% |
| 2019 FY | 27.34 Billion USD | -5.44% |
| 2019 Q1 | 29.04 Billion USD | 0.46% |
| 2019 Q3 | 27.33 Billion USD | -6.23% |
| 2018 Q2 | 30.23 Billion USD | -1.67% |
| 2018 Q1 | 30.75 Billion USD | -5.31% |
| 2018 FY | 28.91 Billion USD | -10.96% |
| 2018 Q4 | 28.91 Billion USD | -1.94% |
| 2018 Q3 | 29.48 Billion USD | -2.47% |
| 2017 Q1 | 34.63 Billion USD | -3.25% |
| 2017 Q3 | 34.7 Billion USD | -1.0% |
| 2017 FY | 32.47 Billion USD | -9.29% |
| 2017 Q2 | 35.05 Billion USD | 1.2% |
| 2017 Q4 | 32.47 Billion USD | -6.42% |
| 2016 Q1 | 10.2 Billion USD | 2.33% |
| 2016 FY | 35.8 Billion USD | 259.15% |
| 2016 Q3 | 36.85 Billion USD | 237.56% |
| 2016 Q4 | 35.8 Billion USD | -2.86% |
| 2016 Q2 | 10.91 Billion USD | 7.04% |
| 2015 Q3 | 11.66 Billion USD | -6.82% |
| 2015 FY | 9.96 Billion USD | -3.48% |
| 2015 Q2 | 12.51 Billion USD | 13.62% |
| 2015 Q1 | 11.01 Billion USD | 6.68% |
| 2015 Q4 | 9.96 Billion USD | -14.54% |
| 2014 Q2 | 11.17 Billion USD | -5.31% |
| 2014 Q1 | 11.79 Billion USD | -3.24% |
| 2014 Q4 | 10.32 Billion USD | -3.03% |
| 2014 FY | 10.32 Billion USD | -15.29% |
| 2014 Q3 | 10.65 Billion USD | -4.66% |
| 2013 Q1 | 12.65 Billion USD | -14.0% |
| 2013 Q2 | 12.45 Billion USD | -1.57% |
| 2013 FY | 12.19 Billion USD | -17.17% |
| 2013 Q4 | 12.19 Billion USD | -3.22% |
| 2013 Q3 | 12.59 Billion USD | 1.11% |
| 2012 FY | 14.71 Billion USD | 1.39% |
| 2012 Q1 | 14.52 Billion USD | 0.04% |
| 2012 Q4 | 14.71 Billion USD | 6.73% |
| 2012 Q2 | 14.04 Billion USD | -3.28% |
| 2012 Q3 | 13.79 Billion USD | -1.82% |
| 2011 Q2 | 6.37 Billion USD | -5.57% |
| 2011 Q1 | 6.75 Billion USD | -1.85% |
| 2011 Q4 | 14.51 Billion USD | 77.48% |
| 2011 Q3 | 8.17 Billion USD | 28.24% |
| 2011 FY | 14.51 Billion USD | 162.54% |
| 2010 Q1 | 6.11 Billion USD | 8.91% |
| 2010 Q4 | 6.88 Billion USD | -3.74% |
| 2010 Q3 | 7.14 Billion USD | 1.87% |
| 2010 Q2 | 7.01 Billion USD | 14.81% |
| 2010 FY | 5.52 Billion USD | -12.78% |
| 2009 FY | 6.33 Billion USD | -24.92% |
| 2009 Q2 | 7.4 Billion USD | -18.29% |
| 2009 Q3 | 6.44 Billion USD | -12.89% |
| 2009 Q4 | 5.61 Billion USD | -12.95% |
| 2009 Q1 | 9.05 Billion USD | 7.28% |
| 2008 Q2 | 4.75 Billion USD | -11.71% |
| 2008 Q1 | 5.38 Billion USD | 3.7% |
| 2008 FY | 8.44 Billion USD | 62.74% |
| 2008 Q3 | 4.66 Billion USD | -1.89% |
| 2008 Q4 | 8.44 Billion USD | 81.18% |
| 2007 Q1 | 5.52 Billion USD | 3.75% |
| 2007 Q2 | 5.5 Billion USD | -0.4% |
| 2007 Q3 | 5.31 Billion USD | -3.54% |
| 2007 Q4 | 5.18 Billion USD | -2.3% |
| 2007 FY | 5.18 Billion USD | -2.61% |
| 2006 FY | 5.32 Billion USD | 147.91% |
| 2006 Q3 | 5.4 Billion USD | -4.14% |
| 2006 Q4 | 5.32 Billion USD | -1.49% |
| 2006 Q1 | 5.65 Billion USD | 163.31% |
| 2006 Q2 | 5.64 Billion USD | -0.29% |
| 2005 Q2 | 1.93 Billion USD | -4.12% |
| 2005 Q1 | 2.01 Billion USD | -2.79% |
| 2005 FY | 2.14 Billion USD | 3.62% |
| 2005 Q4 | 2.14 Billion USD | 12.9% |
| 2005 Q3 | 1.9 Billion USD | -1.53% |
| 2004 Q4 | 2.07 Billion USD | -4.65% |
| 2004 Q3 | 2.17 Billion USD | -14.97% |
| 2004 Q2 | 2.55 Billion USD | -1.92% |
| 2004 Q1 | 2.6 Billion USD | 78.67% |
| 2004 FY | 2.07 Billion USD | 42.08% |
| 2003 Q4 | 1.45 Billion USD | -9.27% |
| 2003 Q3 | 1.6 Billion USD | 0.56% |
| 2003 Q2 | 1.59 Billion USD | -17.24% |
| 2003 Q1 | 1.93 Billion USD | 1.75% |
| 2003 FY | 1.45 Billion USD | -23.17% |
| 2002 Q3 | 1.41 Billion USD | -0.74% |
| 2002 Q2 | 1.42 Billion USD | 1.56% |
| 2002 Q1 | 1.4 Billion USD | -3.14% |
| 2002 FY | 1.89 Billion USD | 30.72% |
| 2002 Q4 | 1.89 Billion USD | 33.88% |
| 2001 Q4 | 1.45 Billion USD | -0.25% |
| 2001 FY | 1.45 Billion USD | 25.79% |
| 2001 Q1 | 1.02 Billion USD | -11.21% |
| 2001 Q2 | 994.87 Million USD | -3.03% |
| 2001 Q3 | 1.45 Billion USD | 46.46% |
| 2000 Q1 | 677.9 Million USD | 1.53% |
| 2000 FY | 1.15 Billion USD | 73.05% |
| 2000 Q2 | 882.42 Million USD | 30.17% |
| 2000 Q4 | 1.15 Billion USD | 0.0% |
| 2000 Q3 | - USD | -100.0% |
| 1999 Q2 | 489.7 Million USD | -5.9% |
| 1999 Q3 | 744.9 Million USD | 52.11% |
| 1999 Q4 | 667.67 Million USD | -10.37% |
| 1999 FY | 667.67 Million USD | 26.89% |
| 1999 Q1 | 520.4 Million USD | -1.1% |
| 1998 Q3 | 534.4 Million USD | 14.58% |
| 1998 Q2 | 466.4 Million USD | 40.31% |
| 1998 Q1 | 332.4 Million USD | -10.09% |
| 1998 Q4 | 526.2 Million USD | -1.53% |
| 1998 FY | 526.2 Million USD | 42.33% |
| 1997 Q4 | 369.7 Million USD | 0.0% |
| 1997 FY | 369.7 Million USD | -26.4% |
| 1996 Q4 | 502.3 Million USD | 0.0% |
| 1996 FY | 502.3 Million USD | 72.49% |
| 1995 FY | 291.2 Million USD | 32.91% |
| 1995 Q4 | 291.2 Million USD | 0.0% |
| 1994 FY | 219.1 Million USD | 22.68% |
| 1994 Q4 | 219.1 Million USD | 0.0% |
| 1993 FY | 178.6 Million USD | 33.58% |
| 1993 Q4 | 178.6 Million USD | 0.0% |
| 1992 Q4 | 133.7 Million USD | 0.0% |
| 1992 FY | 133.7 Million USD | 16.26% |
| 1991 FY | 115 Million USD | -7.26% |
| 1991 Q4 | 115 Million USD | 0.0% |
| 1990 Q4 | 124 Million USD | 0.0% |
| 1990 FY | 124 Million USD | 35.67% |
| 1989 FY | 91.4 Million USD | 23.01% |
| 1989 Q4 | 91.4 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.75 Billion USD | -632.697% |
| Bausch Health Companies Inc. | 22.38 Billion USD | 9.983% |
| Catalent, Inc. | 4.98 Billion USD | -304.03% |
| Emergent BioSolutions Inc. | 877.5 Million USD | -2196.638% |
| Elanco Animal Health Incorporated | 5.77 Billion USD | -249.03% |
| Perrigo Company plc | 4.07 Billion USD | -394.746% |
| Zoetis Inc. | 6.8 Billion USD | -196.237% |